NIH Asserts Patent Rights To Coronavirus Vaccine Technology; MACPAC Takes Up Specialty Drug Policy

By John Wilkerson / April 5, 2021 at 3:51 PM
The National Institutes of Health is licensing a coronavirus vaccine technology that could be used in a future single-dose coronavirus vaccine. Also this week, congressional Medicaid advisers on Thursday will review draft recommendations for controlling state spending on specialty drugs. The House and Senate are on recess and will return next week. There has been much debate over whether the government should claim patents on coronavirus vaccines and drugs as the solution to high prices and global shortages. For example,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.